15-PGDH Expression in Gastric Cancer: A Potential Role in Anti-Tumor Immunity
15-PGDH Expression in Gastric Cancer: A Potential Role in Anti-Tumor Immunity
复制标题
胃癌中 15-PGDH 的表达:在抗肿瘤免疫中的潜在作用
DOI:
10.2147/cmar.s245726
复制
发表时间:
2020
影响因子:
3.3
通讯作者:
Yongqi Liu
中科院分区:
文献类型:
--
作者:
Yaling Li;Junjie Li;Juanjuan Dong;Lei Zhang;Dongling Liu;Jianzheng He;Yali She;Chengxu Ma;Yongqi Liu
Introduction Host immunity plays a vital role in tumorigenesis, including in tumor invasion and metastasis. However, the precise underlying mechanism remains to be explored. The enzyme 15-PGDH, which plays a key role in prostaglandin degradation, is a critical inflammatory mediator in gastric cancer (GC) tumorigenesis. Materials and Methods Immunohistochemistry was performed to determine 15-PGDH expression in GC and the corresponding adjacent non-neoplastic tissues (n=92). Results The expression of 15-PGDH in GC tissues was significantly lower than that in paracancerous tissues (P<0.001) and found to correspond inversely with GC differentiation (P=0.043) and lymph node metastasis (P=0.046). In contrast, FOXP3 expression was increased in poorly differentiated GC tissues (P=0.001). Kaplan–Meier analysis revealed that GC patients with low expression of 15-PGDH (Log rank test, P=0.007) and high expression of FOXP3 (Log rank test, P=0.009) had shorter overall survival (OS) than those with high 15-PGDH and low FOXP3 expression. OS was also correlated with pathological tumor-node-metastasis stage (Log rank test, P=0.014). Furthermore, using Cox proportional hazard regression, 15-PGDH expression [hazard ratio (HR): 0.605 (0.440–0.833); P=0.002] was identified as an independent factor for OS. Conclusion Our data suggest that 15-PGDH may contribute to anti-tumor immunity by regulating FOXP3+ Treg cells. The findings are useful for the identification of therapeutic targets for the management of GC.
影响因子:
16.8
作者:
Savage PA;Malchow S;Leventhal DS
通讯作者:
Leventhal DS
影响因子:
14.5
作者:
Whiteside TL
通讯作者:
Whiteside TL